Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Trioxidized cysteine and aging: a molecular binomial that extends far beyond classical proteinopathic paradigms

  • Sánchez Milán, José Antonio
  • Mulet, Maria
  • Serra, Aida
  • Gallart Palau, Xavier Ramon
Increased oxidative stress (OS) and the disruption of the equilibrium between the production of reactive oxygen species and antioxidants are key molecular features of unhealthy aging. OS results in the formation of oxidative posttranslational modifications (PTMs), some of which involve cysteine (Cys) residues in aging proteomes, and specifically, the formation of trioxidized Cys (t-Cys), which leads to permanent protein damage. Recent findings in rodents have uncovered that irregular regulation of t-Cys residues in the aging proteome disrupts homeostatic phosphorylation signaling, resulting in alterations to proteins that are analogous to those caused by phosphorylated serine (p-Ser) residues. This work contextualizes these significant findings and discusses the implications and molecular role(s) of t-Cys in the aging proteome. Furthermore, we present novel data, validating the increase of specific t-Cys sites associated with aging in a blood-related circulating human proteome. The scope and findings included here support the hypothesis that t-Cys residues may serve as important mechanistic and biological markers, warranting further exploration in the context of unhealthy aging and age-related major diseases., Support for this work was provided by the National Institute of Health/Instituto de Salud Carlos III-ISCIII, Spain PI22/00443 and DTS24/00141 to X.G.-P.), grant co-funded by the European Union; the Ministry of Science and Innovation-MCIN, Spain and the National Research Council/Agencia Estatal de Investigación-AEI, Spain (PID2020-114885RB-C21 to A.S.) funded by MCIN/AEI/10.13039/501100011033. This research was also co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU; from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1); and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health ((EVBRAINTARGET-Y7340-ACPPCCOL007 to X.G.-P. and A.S) coordinated by the Institute for Bioengineering of Catalonia (IBEC)); the Diputació de Lleida, Spain (PIRS22/03 to X.G.-P. and PIRS23/02 to A.S.); the Catalan Research Council-AGAUR (2023 LLAV 00056 to X.G.-P.; and 2022 DI 100 to X.G.-P. X.G.-P. acknowledges a Miguel Servet program tenure track contract (CP21/00096) from the ISCIII, awarded on the 2021 call under the Health Strategy Action, co-funded by the European Union (FSE+). A.S. acknowledges a Ramón y Cajal program tenure track contract (RYC2021-030946-I) funded by MCIN/AEI/ 10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR. J.A.S.M.’s PhD scholarship (2023 FI-1 00054) is funded by AGAUR. M.M.’s PhD scholarship (PRE2021-097934) is funded by MCIN/AEI/ 10.13039/501100011033 and by “FSE+”. IRBLLEIDA, J.A.S.M., X.G.-P., and A.S. are co-funded by the CERCA Program/Generalitat de Catalunya. X.G.-P. is member of the ExoPsyCog Consortium, funded
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Differential systemic decellularization in vivo to study molecular changes in each vasculature layer in murine models of disease

  • Gallart Palau, Xavier Ramon
  • Lorca, Cristina
  • Mulet, Maria
  • Sánchez Milán, José Antonio
  • Lisa, Julia
  • Cam Ngan, SoFong
  • Iyappan, Ranjith
  • Katoueezadeh, Maryam
  • Serra, Aida
  • Kwan Sze, Siu
Vascular dysfunction underlies the onset and progression of many life-threatening diseases, highlighting the need for improved understanding of its molecular basis. Here, we present differential systemic decellularization in vivo (DISDIVO), a protocol that enables systemic and independent study of the molecular changes in each vasculature layer in murine models of disease. We describe steps for anesthesia, perfusion surgery, and exsanguination. We then detail detachment and collection of glycocalyx and decellularization and collection of both endothelial and smooth muscle cells. For complete details on the use and execution of this protocol, please refer to Serra et al., Gallart-Palau et al., and Vinaiphat et al., The authors thank Prof Xavier Dolcet (Basic Medical Sciences Department, University of Lleida) and Laura Casani (IR-Sant Pau - Sant Pau Institute of Biomedical Research, Barcelona) for their help with the protocol revisions. Support for this work was provided by the National Institute of Health/Instituto de Salud Carlos III-ISCIII, Spain (PI22/00443 to X.G.-P.), grant co-funded by the European Union; the Ministry of Science and Innovation-MCIN, Spain, and the National Research Council/ Agencia Estatal de Investigacio´ n-AEI, Spain (PID2020-114885RB-C21 to A.S.), funded by MCIN/ AEI/10.13039/501100011033; the MCIN with funds from the European Union NextGenerationEU (PRTR-C17.I1) and the Autonomous Community of Catalonia ‘‘Biotechnology Plan Applied to Health’’ (EVBRAINTARGET-Y7340-ACPPCCOL007 to X.G.-P. and A.S.), coordinated by the Institute for Bioengineering of Catalonia (IBEC); and the Diputacio´ de Lleida, Spain (PIRS22/03 to X.G.-P.). X.G.-P. acknowledges a Miguel Servet program tenure track contract (CP21/00096) of the ISCIII, awarded on the 2021 call under the Health Strategy Action, co-funded by the European Union (FSE+). A.S. acknowledges a Ramo´ n y Cajal program tenure track contract (RYC2021-030946-I) of the AEI, funded by MCIN/AEI/ 10.13039/501100011033 and by ‘‘ESF Investing in your future.’’ C.L.’s PhD is funded by the European Social Fund for the recruitment of predoctoral researchers (PEJD-2019-PRE/BIO- 16475), M.M.’s PhD is funded by the MCIN-AEI (PR2021-097934), J.A.S.M.’s PhD is funded by the Catalan Research Council-AGAUR (2023 FI-1 00054) and the contributions have also been supported by Diputacio´ de Lleida, Spain ‘‘Ajuts al Talent en Investigacio´ Biome` dica,’’ J.L.’s PhD is funded by AGAUR, Spain (2022 DI 100) and by the company Alge` mica Barcelona S.L. IRBLleida. J.A.S.M., X.G.-P., and A.S. are co-funded by the CERCA Program/Generalitat de Catalunya. Support for this work has also been provided by the Singapore National Medical Research Council (NMRC/OFIRG/0003/2016 to S.K.S.), Canadian Institutes of Health Research Tier 1 Canada Research Chair (to S.K.S.), Canadian Institutes of Health Research Project Grant (to S.K.S.), The Natural Sciences and Engineering Research Council of Canada Discovery Grant (to S.K.S.), Canada Foundation for Innovation grant (to S.K.S.), and start-up research grant from Brock University (to S.K.S.).
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Industrial By-Products As a Novel Circular Source of Biocompatible Extracellular Vesicles

  • Lorca, Cristina
  • Laparra, Moisés
  • Céspedes, María Virtudes
  • Casaní, Laura
  • Florit, Sergi
  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Vilella, Elisabet
  • Gallart Palau, Xavier Ramon
  • Serra, Aida
Extracellular vesicles (EVs) constitute an intricate system of molecular exchange that has recently gained tremendous interest. However, sustainable sources of safe biological EVs remain scarce and elusive. This study explores and defines the use of food industry by-products (BP) as a circular source of safe biocompatible EVs. Averaged diameter and molecular compositions indicate a large yield of exosomes and high abundancy of membrane lipids with signaling capacity in these vesicles. Complex proteomes mimicking those circulating in human blood plasma are also identified. Furthermore, BP-EVs do not show relevant cytotoxicity and display excellent oral and intravenous bioavailability together with specific organ targeting capacity. Collectively, it is believed that the novel findings reported here will open substantial venues for the use of BP as an optimal source of biocompatible nanovesicles in manifold applications of the biotechnological and biomedical fields., The authors sincerely thank Gemma Plaza, oenologist at the Castell del Remei winery in Penelles, Lleida, Spain and Juan Carlos Blanco, production manager at Mahou San Miguel in Alovera, Madrid, Spain for their kind and altruistic help on the obtention of their respective industry by-product samples. The authors also thank Dr. Hector Peinado and his research group at the National Center for Oncology Research (CNIO) in Madrid (Spain) for their support on the morphometric characterization of BP-EVs. Support for this work was provided by the Research and Education Council of the Community of Madrid, Spain (2018-T1/ BIO-10633), Ministry of Science and Innovation, Spain (PID2020- 114885RB-C21) and a FIS project by Carlos III Institute of Health (ISCIII), Spain (PI20/00623). A.S. acknowledges a grant from the Talento Program 2018 of the Community of Madrid. X.G.-P. acknowledges grants from Sara Borrell postdoctoral program (CD19/00243) and Miguel Servet tenure track program (CP21/00096) of the Instituto de Salud Carlos III (ISCIII, Spain), respectively awarded on the 2019 and 2021 calls under ISCIII-Health Strategy Actions [These grants are cofunded with European Union Funds (ISCIII Miguel Servet Program 2021 is cofunded by Fondo Social Europeo Plus, FSE+)]. M.V.C. acknowledges a Miguel Servet program contract (CPII20/00007). C.L.’s Ph.D. was funded by the Regional Ministry of Science, Universities and Innovation of the Community of Madrid and the European Social Fund for the recruitment of predoctoral researchers (PEJD-2019-PRE/BIO-16475). IRBLLEIDA and X.G.-P. are co-funded by CERCA Program/Generalitat de Catalunya.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Oral Microbiota, Its Equilibrium and Implications in the Pathophysiology of Human Diseases: A Systematic Review

  • Giordano Kelhoffer, Barbara
  • Lorca, Cristina
  • March Llanes, Jaume
  • Rábano, Alberto
  • Del Ser, Teodoro
  • Serra, Aida
  • Gallart Palau, Xavier Ramon
Imbalances of the oral microbiota and dysbiosis have traditionally been linked to theoccurrence of teeth and oral diseases. However, recent findings indicate that this microbiota exertsrelevant influence in systemic health. Dysbiosis of the oral microbiota is implicated in the apparitionand progression of cardiovascular, neurodegenerative and other major human diseases. In fact,the oral microbiota are the second most diverse and largely populated microbiota of the humanbody and its relationships with systemic health, although widely explored, they still lack of properintegration. The purpose of this systematic review is thus to widely examine the implications of oralmicrobiota in oral, cardiovascular and neurodegenerative diseases to offer integrative and up-to-dateinterpretations. To achieve that aim, we identified a total of 121 studies curated in PUBMED from thetime interval January 2003–April 2022, which after careful screening resulted in 79 studies included.The reviewed scientific literature provides plausible vias of implication of dysbiotic oral microbiota insystemic human diseases, and encourages further research to continue elucidating the highly relevantand still poorly understood implications of this niche microbiota in systemic health. PROSPERORegistration Number: CRD42022299692. This systematic review follows relevant PRISMA guidelines., Support for this work was provided by the Ministry of Science and Innovation, Spain(PID2020-114885RB-C21), Research and Education Council of the Comunidad de Madrid, Spain(2018-T1/BIO-10633) and the National Health Institute: Instituto de Salud Carlos III (ISCIII), Spain(CP21/00096). A.S. acknowledges a grant from the Talento Program 2018 of the Comunidadde Madrid. X.G.-P. acknowledges a grant from the 2021 Miguel Servet tenure track program(CP21/00096) awarded by ISCIII (Miguel Servet Program 2021 is co-funded by European UnionFunds: Fondo Social Europeo Plus, FSE+). IRBLLEIDA and X.G.-P. are co-funded by the CERCAProgram/Generalitat de Catalunya. C.L.’s PhD is funded by the Regional Ministry of Science, Univer-sities and Innovation of the Community of Madrid and the European Social Fund for the recruitmentof predoctoral researchers (PEJD-2019-PRE/BIO-16475).
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Brain and circulating EV proteome signatures in schizophrenia as prognostic markers for age-related dementia

  • Sánchez Milán, Jose Antonio
  • Mulet, Maria
  • Molet, Itziar
  • Lisa Molina, Julia
  • Font Alberich, Maria
  • Lorca, Cristina
  • Gea Sánchez, Montserrat
  • Bellon, Filip
  • Batalla, Iolanda
  • Meana, Javier
  • Callado, Luis
  • Morentin, Benito
  • Ramos Miguel, Alfredo
  • Kalaria, Raj
  • Serra Maqueda, Aida
  • Gallart Palau, Xavier Ramon
Schizophrenia (SZ) is epidemiologically linked to an increased risk of developing age-related dementias (ARD) predominantly characterized by Alzheimer's disease and vascular dementia. However, the molecular mechanisms underlying this association remain insufficiently elucidated. Extracellular vesicles (EVs) play a critical role in neuropathological processes and offer a promising avenue for identifying shared disease mechanisms and potential circulating markers for patient stratification. Here we used a two-phase systems biology approach integrating discovery-driven proteomics with a targeted validation strategy using data-independent acquisition mass spectrometry (DIA-MS) in a large, independent SZ cohort. First, we analyzed brain-derived EVs (bEVs) from post-mortem SZ and ARD subjects to identify shared molecular signatures. Next, we validated the presence and circulation of these bEV markers in circulating plasma EVs (pEVs) using DIA-MS data. Remarkably, SZ and ARD bEV proteome and peptidome showed overlapping alterations in neuronal connectivity, synaptic integrity, neuroinflammation, and metabolism. Unsupervised clustering analysis of correlated bEV/pEV markers stratified SZ patients into two clusters: high dementia risk and control-like profiles. Collectively, these data emphasize the significance of bEVs as crucial mediators of shared neuropathogenic mechanisms in SZ, and ARD. Furthermore, we identified a set of pEVs markers, including proteins and specific peptides, with a robust and promising bench-to-bedside trajectory that may facilitate the stratification of SZ patients at risk for ARD., The authors are pleased to acknowledge to Spanish Ministry of Science and Innovation, research project QUALISAFEJUICE PID-2019-106645RB-I00, for its financial support. I. Neggazi thanks the University of Lleida for its predoctoral grant (BOU204-220/2020 UdL) and the Serra Húnter contract awarded to Pilar Colás-Medà for supporting this work. This work also received support from the PT national funds (FCT/MECI, Fundação para a Ciência e Tecnologia and Ministério da Educação, Ciência e Inovação) through the project UID/50006 – Laboratório Associado para a Química Verde - Tecnologias e Processos Limpos. This study was also funded by the PRR – Plano de Recuperação e Resiliência and by the NextGenerationEU funds at Universidade de Aveiro, through the scope of the Agenda for Business Innovation “Plataforma de Valorização, Industrialização e Inovação comercial para o AgroAlimentar (VIIAFOOD)” (Project no. 37 AAC n.° 02/C05-i01/2022 with the application C644929456-00000040).
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Editorial: Food Proteomes: Beyond Their Nutritional Value

  • Gallart Palau, Xavier Ramon
  • Hemu, Xinya
  • Motilva Casado, Mª José
  • Serra, Aida
Support for this work was provided by Research and Education Council of the Comunidad de Madrid (2018-T1/BIO-10633) and Ministry of Science and Innovation, (PID2020-114885RB-C21), Spain. AS acknowledges a grant from the Talento Program 2018 of the Comunidad de Madrid. XG-P acknowledges grants from the Sara Borrell Program (CD19/00243) and Miguel Servet Program (CP21/00096), Carlos III Institute of Health, Spain, respectively awarded on the 2019 and 2021 calls.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome

  • Lorca, Cristina
  • Fernández-Rhodes, María
  • Sánchez Milán, José Antonio
  • Mulet, Maria
  • Elortza, Félix
  • Ramos-Miguel, Alfredo
  • Callado, Luis F.
  • Meana, J. Javier
  • Mur, Maria
  • Batalla, Iolanda
  • Vilella, Elisabet
  • Serra, Aida
  • Gallart-Palau, Xavier
Extracellular vesicles (EVs) are tiny membranous structures that mediate intercellular communication. The role(s) of these vesicles have been widely investigated in the context of neurological diseases; however, their potential implications in the neuropathology subjacent to human psychiatric disorders remain mostly unknown. Here, by using next-generation discovery-driven proteomics, we investigate the potential role(s) of brain EVs (bEVs) in schizophrenia (SZ) by analyzing these vesicles from the three post-mortem anatomical brain regions: the prefrontal cortex (PFC), hippocampus (HC), and caudate (CAU). The results obtained indicate that bEVs from SZ-affected brains contain region-specific proteins that are associated with abnormal GABAergic and glutamatergic transmission. Similarly, these vesicles from the analyzed regions were implicated in synaptic decay, abnormal brain immunity, neuron structural imbalances, and impaired cell homeostasis. Our findings also provide evidence, for the first time, that networks of molecular exchange (involving the PFC, HC, and CAU) are potentially active and mediated by EVs in non-diseased brains. Additionally, these bEV-mediated networks seem to have become partially reversed and largely disrupted in the brains of subjects affected by SZ. Taken as a whole, these results open the door to the uncovering of new biological markers and therapeutic targets, based on the compositions of bEVs, for the benefit of patients affected by SZ and related psychotic disorders., : Support for this work was provided by the National Institute of Health/Instituto de Salud Carlos III-ISCIII, Spain (PI22/00443 to X.G.-P.) (grant co-funded by the European Union); the Ministry of Science and Innovation-MCIN, Spain and the National Research Council/Agencia Estatal de Investigación-AEI, Spain (PID2020-114885RB-C21 to A.S.) funded by MCIN/AEI/10.13039/501100011033. This research was also co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU; from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1); and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health ((EVBRAINTARGET-Y7340-ACPPCCOL007 to X.G.-P., A.S., M.Mur, and A.R.-M.) coordinated by the Institute for Bioengineering of Catalonia (IBEC)); the Diputació de Lleida, Spain (PIRS22/03 to X.G.-P. & I.B. and PIRS23/02 to A.S.); the Catalan Research Council-AGAUR (AGAUR 21SGR010065 to E.V.; 2023 LLAV 00056 to X.G.-P.; and 2022 DI 100 to X.G.-P.); and the Basque Government (IT211/19 and IT1512/22 to J.J.M and L.F.C.). X.G.- P. acknowledges a Miguel Servet program tenure track contract (CP21/00096) from the ISCIII, awarded on the 2021 call under the Health Strategy Action, co-funded by the European Union (FSE+). A.S. acknowledges a Ramón y Cajal program tenure track contract (RYC2021-030946-I) funded by MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”; A.R.-M. acknowledges a Ramón y Cajal program tenure track contract (RYC-2016-19282) funded by MCIN/AEI/10.13039/501100011033. M.F.-R.’s postdoctoral contract is funded by PRTR-C17.I1 and EVBRAINTARGET-Y7340-ACPPCCOL007. C.L.’s PhD is funded by the European Social Fund for the recruitment of predoctoral researchers (PEJD-2019-PRE/BIO-16475); M.M.’s PhD is funded by the MCIN-AEI (PR2021-097934); and J.A.S.M.’s PhD is funded by AGAUR (2023 FI-1 00054), and J.A.S.M.’s contributions were also supported by Diputació de Lleida ‘Ajuts al Talent en Investigació Biomèdica”. IRBLLEIDA, J.A.S.M., X.G.-P., and A.S. are co-funded by the CERCA Program/Generalitat de Catalunya. J.J.M., A.R.-M., and X.G.-P. are members of the ExoPsyCog Consortium, funded by IKUR-Neurobiosciences—Basque Government.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Editorial: Food Proteomes: Beyond Their Nutritional Value

  • Gallart-Palau, Xavier
  • Hemu, Xinya
  • Motilva, María-José
  • Serra, Aida
This Research Topic collects diverse studies focused on the in-depth characterization of dietary proteomes by evaluating their singular features, possible roles in health and disease conditions; as well as exploring the changes caused by industrial processing to food proteomes. Of note, characterization of dietary proteomes has been performed by using high throughput mass spectrometry strategies in all compiled studies., Support for this work was provided by Research and Education Council of the Comunidad de Madrid (2018-T1/BIO-10633) and Ministry of Science and Innovation, (PID2020-114885RB-C21), Spain. AS acknowledges a grant from the Talento Program 2018 of the Comunidad de Madrid. XG-P acknowledges grants from the Sara Borrell Program (CD19/00243) and Miguel Servet Program (CP21/00096), Carlos III Institute of Health, Spain, respectively awarded on the 2019 and 2021 calls.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Trioxidized cysteine and aging: a molecular binomial that extends far beyond classical proteinopathic paradigms

  • Sánchez Milán, José Antonio
  • Mulet, Maria
  • Serra, Aida
  • Gallart Palau, Xavier Ramon
Increased oxidative stress (OS) and the disruption of the equilibrium between the production of reactive oxygen species and antioxidants are key molecular features of unhealthy aging. OS results in the formation of oxidative posttranslational modifications (PTMs), some of which involve cysteine (Cys) residues in aging proteomes, and specifically, the formation of trioxidized Cys (t-Cys), which leads to permanent protein damage. Recent findings in rodents have uncovered that irregular regulation of t-Cys residues in the aging proteome disrupts homeostatic phosphorylation signaling, resulting in alterations to proteins that are analogous to those caused by phosphorylated serine (p-Ser) residues. This work contextualizes these significant findings and discusses the implications and molecular role(s) of t-Cys in the aging proteome. Furthermore, we present novel data, validating the increase of specific t-Cys sites associated with aging in a blood-related circulating human proteome. The scope and findings included here support the hypothesis that t-Cys residues may serve as important mechanistic and biological markers, warranting further exploration in the context of unhealthy aging and age-related major diseases., Support for this work was provided by the National Institute of Health/Instituto de Salud Carlos III-ISCIII, Spain PI22/00443 and DTS24/00141 to X.G.-P.), grant co-funded by the European Union; the Ministry of Science and Innovation-MCIN, Spain and the National Research Council/Agencia Estatal de Investigación-AEI, Spain (PID2020-114885RB-C21 to A.S.) funded by MCIN/AEI/10.13039/501100011033. This research was also co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU; from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1); and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health ((EVBRAINTARGET-Y7340-ACPPCCOL007 to X.G.-P. and A.S) coordinated by the Institute for Bioengineering of Catalonia (IBEC)); the Diputació de Lleida, Spain (PIRS22/03 to X.G.-P. and PIRS23/02 to A.S.); the Catalan Research Council-AGAUR (2023 LLAV 00056 to X.G.-P.; and 2022 DI 100 to X.G.-P. X.G.-P. acknowledges a Miguel Servet program tenure track contract (CP21/00096) from the ISCIII, awarded on the 2021 call under the Health Strategy Action, co-funded by the European Union (FSE+). A.S. acknowledges a Ramón y Cajal program tenure track contract (RYC2021-030946-I) funded by MCIN/AEI/ 10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR. J.A.S.M.’s PhD scholarship (2023 FI-1 00054) is funded by AGAUR. M.M.’s PhD scholarship (PRE2021-097934) is funded by MCIN/AEI/ 10.13039/501100011033 and by “FSE+”. IRBLLEIDA, J.A.S.M., X.G.-P., and A.S. are co-funded by the CERCA Program/Generalitat de Catalunya. X.G.-P. is member of the ExoPsyCog Consortium, funded
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Industrial By-Products As a Novel Circular Source of Biocompatible Extracellular Vesicles

  • Lorca, Cristina
  • Laparra, Moisés
  • Céspedes, María Virtudes
  • Casaní, Laura
  • Florit, Sergi
  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Vilella, Elisabet
  • Gallart Palau, Xavier Ramon
  • Serra, Aida
Extracellular vesicles (EVs) constitute an intricate system of molecular exchange that has recently gained tremendous interest. However, sustainable sources of safe biological EVs remain scarce and elusive. This study explores and defines the use of food industry by-products (BP) as a circular source of safe biocompatible EVs. Averaged diameter and molecular compositions indicate a large yield of exosomes and high abundancy of membrane lipids with signaling capacity in these vesicles. Complex proteomes mimicking those circulating in human blood plasma are also identified. Furthermore, BP-EVs do not show relevant cytotoxicity and display excellent oral and intravenous bioavailability together with specific organ targeting capacity. Collectively, it is believed that the novel findings reported here will open substantial venues for the use of BP as an optimal source of biocompatible nanovesicles in manifold applications of the biotechnological and biomedical fields., The authors sincerely thank Gemma Plaza, oenologist at the Castell del Remei winery in Penelles, Lleida, Spain and Juan Carlos Blanco, production manager at Mahou San Miguel in Alovera, Madrid, Spain for their kind and altruistic help on the obtention of their respective industry by-product samples. The authors also thank Dr. Hector Peinado and his research group at the National Center for Oncology Research (CNIO) in Madrid (Spain) for their support on the morphometric characterization of BP-EVs. Support for this work was provided by the Research and Education Council of the Community of Madrid, Spain (2018-T1/ BIO-10633), Ministry of Science and Innovation, Spain (PID2020- 114885RB-C21) and a FIS project by Carlos III Institute of Health (ISCIII), Spain (PI20/00623). A.S. acknowledges a grant from the Talento Program 2018 of the Community of Madrid. X.G.-P. acknowledges grants from Sara Borrell postdoctoral program (CD19/00243) and Miguel Servet tenure track program (CP21/00096) of the Instituto de Salud Carlos III (ISCIII, Spain), respectively awarded on the 2019 and 2021 calls under ISCIII-Health Strategy Actions [These grants are cofunded with European Union Funds (ISCIII Miguel Servet Program 2021 is cofunded by Fondo Social Europeo Plus, FSE+)]. M.V.C. acknowledges a Miguel Servet program contract (CPII20/00007). C.L.’s Ph.D. was funded by the Regional Ministry of Science, Universities and Innovation of the Community of Madrid and the European Social Fund for the recruitment of predoctoral researchers (PEJD-2019-PRE/BIO-16475). IRBLLEIDA and X.G.-P. are co-funded by CERCA Program/Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Differential systemic decellularization in vivo to study molecular changes in each vasculature layer in murine models of disease

  • Gallart Palau, Xavier Ramon
  • Lorca, Cristina
  • Mulet, Maria
  • Sánchez Milán, José Antonio
  • Lisa, Julia
  • Cam Ngan, SoFong
  • Iyappan, Ranjith
  • Katoueezadeh, Maryam
  • Serra, Aida
  • Kwan Sze, Siu
Vascular dysfunction underlies the onset and progression of many life-threatening diseases, highlighting the need for improved understanding of its molecular basis. Here, we present differential systemic decellularization in vivo (DISDIVO), a protocol that enables systemic and independent study of the molecular changes in each vasculature layer in murine models of disease. We describe steps for anesthesia, perfusion surgery, and exsanguination. We then detail detachment and collection of glycocalyx and decellularization and collection of both endothelial and smooth muscle cells. For complete details on the use and execution of this protocol, please refer to Serra et al., Gallart-Palau et al., and Vinaiphat et al., The authors thank Prof Xavier Dolcet (Basic Medical Sciences Department, University of Lleida) and Laura Casani (IR-Sant Pau - Sant Pau Institute of Biomedical Research, Barcelona) for their help with the protocol revisions. Support for this work was provided by the National Institute of Health/Instituto de Salud Carlos III-ISCIII, Spain (PI22/00443 to X.G.-P.), grant co-funded by the European Union; the Ministry of Science and Innovation-MCIN, Spain, and the National Research Council/ Agencia Estatal de Investigacio´ n-AEI, Spain (PID2020-114885RB-C21 to A.S.), funded by MCIN/ AEI/10.13039/501100011033; the MCIN with funds from the European Union NextGenerationEU (PRTR-C17.I1) and the Autonomous Community of Catalonia ‘‘Biotechnology Plan Applied to Health’’ (EVBRAINTARGET-Y7340-ACPPCCOL007 to X.G.-P. and A.S.), coordinated by the Institute for Bioengineering of Catalonia (IBEC); and the Diputacio´ de Lleida, Spain (PIRS22/03 to X.G.-P.). X.G.-P. acknowledges a Miguel Servet program tenure track contract (CP21/00096) of the ISCIII, awarded on the 2021 call under the Health Strategy Action, co-funded by the European Union (FSE+). A.S. acknowledges a Ramo´ n y Cajal program tenure track contract (RYC2021-030946-I) of the AEI, funded by MCIN/AEI/ 10.13039/501100011033 and by ‘‘ESF Investing in your future.’’ C.L.’s PhD is funded by the European Social Fund for the recruitment of predoctoral researchers (PEJD-2019-PRE/BIO- 16475), M.M.’s PhD is funded by the MCIN-AEI (PR2021-097934), J.A.S.M.’s PhD is funded by the Catalan Research Council-AGAUR (2023 FI-1 00054) and the contributions have also been supported by Diputacio´ de Lleida, Spain ‘‘Ajuts al Talent en Investigacio´ Biome` dica,’’ J.L.’s PhD is funded by AGAUR, Spain (2022 DI 100) and by the company Alge` mica Barcelona S.L. IRBLleida. J.A.S.M., X.G.-P., and A.S. are co-funded by the CERCA Program/Generalitat de Catalunya. Support for this work has also been provided by the Singapore National Medical Research Council (NMRC/OFIRG/0003/2016 to S.K.S.), Canadian Institutes of Health Research Tier 1 Canada Research Chair (to S.K.S.), Canadian Institutes of Health Research Project Grant (to S.K.S.), The Natural Sciences and Engineering Research Council of Canada Discovery Grant (to S.K.S.), Canada Foundation for Innovation grant (to S.K.S.), and start-up research grant from Brock University (to S.K.S.).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Brain and circulating EV proteome signatures in schizophrenia as prognostic markers for age-related dementia

  • Sánchez Milán, Jose Antonio
  • Mulet, Maria
  • Molet, Itziar
  • Lisa Molina, Julia
  • Font Alberich, Maria
  • Lorca, Cristina
  • Gea Sánchez, Montserrat
  • Bellon, Filip
  • Batalla, Iolanda
  • Meana, Javier
  • Callado, Luis
  • Morentin, Benito
  • Ramos Miguel, Alfredo
  • Kalaria, Raj
  • Serra Maqueda, Aida
  • Gallart Palau, Xavier Ramon
Schizophrenia (SZ) is epidemiologically linked to an increased risk of developing age-related dementias (ARD) predominantly characterized by Alzheimer's disease and vascular dementia. However, the molecular mechanisms underlying this association remain insufficiently elucidated. Extracellular vesicles (EVs) play a critical role in neuropathological processes and offer a promising avenue for identifying shared disease mechanisms and potential circulating markers for patient stratification. Here we used a two-phase systems biology approach integrating discovery-driven proteomics with a targeted validation strategy using data-independent acquisition mass spectrometry (DIA-MS) in a large, independent SZ cohort. First, we analyzed brain-derived EVs (bEVs) from post-mortem SZ and ARD subjects to identify shared molecular signatures. Next, we validated the presence and circulation of these bEV markers in circulating plasma EVs (pEVs) using DIA-MS data. Remarkably, SZ and ARD bEV proteome and peptidome showed overlapping alterations in neuronal connectivity, synaptic integrity, neuroinflammation, and metabolism. Unsupervised clustering analysis of correlated bEV/pEV markers stratified SZ patients into two clusters: high dementia risk and control-like profiles. Collectively, these data emphasize the significance of bEVs as crucial mediators of shared neuropathogenic mechanisms in SZ, and ARD. Furthermore, we identified a set of pEVs markers, including proteins and specific peptides, with a robust and promising bench-to-bedside trajectory that may facilitate the stratification of SZ patients at risk for ARD., The authors are pleased to acknowledge to Spanish Ministry of Science and Innovation, research project QUALISAFEJUICE PID-2019-106645RB-I00, for its financial support. I. Neggazi thanks the University of Lleida for its predoctoral grant (BOU204-220/2020 UdL) and the Serra Húnter contract awarded to Pilar Colás-Medà for supporting this work. This work also received support from the PT national funds (FCT/MECI, Fundação para a Ciência e Tecnologia and Ministério da Educação, Ciência e Inovação) through the project UID/50006 – Laboratório Associado para a Química Verde - Tecnologias e Processos Limpos. This study was also funded by the PRR – Plano de Recuperação e Resiliência and by the NextGenerationEU funds at Universidade de Aveiro, through the scope of the Agenda for Business Innovation “Plataforma de Valorização, Industrialização e Inovação comercial para o AgroAlimentar (VIIAFOOD)” (Project no. 37 AAC n.° 02/C05-i01/2022 with the application C644929456-00000040).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Oral Microbiota, Its Equilibrium and Implications in the Pathophysiology of Human Diseases: A Systematic Review

  • Giordano Kelhoffer, Barbara
  • Lorca, Cristina
  • March Llanes, Jaume
  • Rábano, Alberto
  • Del Ser, Teodoro
  • Serra, Aida
  • Gallart Palau, Xavier Ramon
Imbalances of the oral microbiota and dysbiosis have traditionally been linked to theoccurrence of teeth and oral diseases. However, recent findings indicate that this microbiota exertsrelevant influence in systemic health. Dysbiosis of the oral microbiota is implicated in the apparitionand progression of cardiovascular, neurodegenerative and other major human diseases. In fact,the oral microbiota are the second most diverse and largely populated microbiota of the humanbody and its relationships with systemic health, although widely explored, they still lack of properintegration. The purpose of this systematic review is thus to widely examine the implications of oralmicrobiota in oral, cardiovascular and neurodegenerative diseases to offer integrative and up-to-dateinterpretations. To achieve that aim, we identified a total of 121 studies curated in PUBMED from thetime interval January 2003–April 2022, which after careful screening resulted in 79 studies included.The reviewed scientific literature provides plausible vias of implication of dysbiotic oral microbiota insystemic human diseases, and encourages further research to continue elucidating the highly relevantand still poorly understood implications of this niche microbiota in systemic health. PROSPERORegistration Number: CRD42022299692. This systematic review follows relevant PRISMA guidelines., Support for this work was provided by the Ministry of Science and Innovation, Spain(PID2020-114885RB-C21), Research and Education Council of the Comunidad de Madrid, Spain(2018-T1/BIO-10633) and the National Health Institute: Instituto de Salud Carlos III (ISCIII), Spain(CP21/00096). A.S. acknowledges a grant from the Talento Program 2018 of the Comunidadde Madrid. X.G.-P. acknowledges a grant from the 2021 Miguel Servet tenure track program(CP21/00096) awarded by ISCIII (Miguel Servet Program 2021 is co-funded by European UnionFunds: Fondo Social Europeo Plus, FSE+). IRBLLEIDA and X.G.-P. are co-funded by the CERCAProgram/Generalitat de Catalunya. C.L.’s PhD is funded by the Regional Ministry of Science, Univer-sities and Innovation of the Community of Madrid and the European Social Fund for the recruitmentof predoctoral researchers (PEJD-2019-PRE/BIO-16475).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Editorial: Food Proteomes: Beyond Their Nutritional Value

  • Gallart Palau, Xavier Ramon
  • Hemu, Xinya
  • Motilva Casado, Mª José
  • Serra, Aida
Support for this work was provided by Research and Education Council of the Comunidad de Madrid (2018-T1/BIO-10633) and Ministry of Science and Innovation, (PID2020-114885RB-C21), Spain. AS acknowledges a grant from the Talento Program 2018 of the Comunidad de Madrid. XG-P acknowledges grants from the Sara Borrell Program (CD19/00243) and Miguel Servet Program (CP21/00096), Carlos III Institute of Health, Spain, respectively awarded on the 2019 and 2021 calls.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome

  • Lorca, Cristina
  • Fernández-Rhodes, María
  • Sánchez Milán, José Antonio
  • Mulet, Maria
  • Elortza, Félix
  • Ramos-Miguel, Alfredo
  • Callado, Luis F.
  • Meana, J. Javier
  • Mur, Maria
  • Batalla, Iolanda
  • Vilella, Elisabet
  • Serra, Aida
  • Gallart-Palau, Xavier
Extracellular vesicles (EVs) are tiny membranous structures that mediate intercellular communication. The role(s) of these vesicles have been widely investigated in the context of neurological diseases; however, their potential implications in the neuropathology subjacent to human psychiatric disorders remain mostly unknown. Here, by using next-generation discovery-driven proteomics, we investigate the potential role(s) of brain EVs (bEVs) in schizophrenia (SZ) by analyzing these vesicles from the three post-mortem anatomical brain regions: the prefrontal cortex (PFC), hippocampus (HC), and caudate (CAU). The results obtained indicate that bEVs from SZ-affected brains contain region-specific proteins that are associated with abnormal GABAergic and glutamatergic transmission. Similarly, these vesicles from the analyzed regions were implicated in synaptic decay, abnormal brain immunity, neuron structural imbalances, and impaired cell homeostasis. Our findings also provide evidence, for the first time, that networks of molecular exchange (involving the PFC, HC, and CAU) are potentially active and mediated by EVs in non-diseased brains. Additionally, these bEV-mediated networks seem to have become partially reversed and largely disrupted in the brains of subjects affected by SZ. Taken as a whole, these results open the door to the uncovering of new biological markers and therapeutic targets, based on the compositions of bEVs, for the benefit of patients affected by SZ and related psychotic disorders., : Support for this work was provided by the National Institute of Health/Instituto de Salud Carlos III-ISCIII, Spain (PI22/00443 to X.G.-P.) (grant co-funded by the European Union); the Ministry of Science and Innovation-MCIN, Spain and the National Research Council/Agencia Estatal de Investigación-AEI, Spain (PID2020-114885RB-C21 to A.S.) funded by MCIN/AEI/10.13039/501100011033. This research was also co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU; from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1); and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health ((EVBRAINTARGET-Y7340-ACPPCCOL007 to X.G.-P., A.S., M.Mur, and A.R.-M.) coordinated by the Institute for Bioengineering of Catalonia (IBEC)); the Diputació de Lleida, Spain (PIRS22/03 to X.G.-P. & I.B. and PIRS23/02 to A.S.); the Catalan Research Council-AGAUR (AGAUR 21SGR010065 to E.V.; 2023 LLAV 00056 to X.G.-P.; and 2022 DI 100 to X.G.-P.); and the Basque Government (IT211/19 and IT1512/22 to J.J.M and L.F.C.). X.G.- P. acknowledges a Miguel Servet program tenure track contract (CP21/00096) from the ISCIII, awarded on the 2021 call under the Health Strategy Action, co-funded by the European Union (FSE+). A.S. acknowledges a Ramón y Cajal program tenure track contract (RYC2021-030946-I) funded by MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”; A.R.-M. acknowledges a Ramón y Cajal program tenure track contract (RYC-2016-19282) funded by MCIN/AEI/10.13039/501100011033. M.F.-R.’s postdoctoral contract is funded by PRTR-C17.I1 and EVBRAINTARGET-Y7340-ACPPCCOL007. C.L.’s PhD is funded by the European Social Fund for the recruitment of predoctoral researchers (PEJD-2019-PRE/BIO-16475); M.M.’s PhD is funded by the MCIN-AEI (PR2021-097934); and J.A.S.M.’s PhD is funded by AGAUR (2023 FI-1 00054), and J.A.S.M.’s contributions were also supported by Diputació de Lleida ‘Ajuts al Talent en Investigació Biomèdica”. IRBLLEIDA, J.A.S.M., X.G.-P., and A.S. are co-funded by the CERCA Program/Generalitat de Catalunya. J.J.M., A.R.-M., and X.G.-P. are members of the ExoPsyCog Consortium, funded by IKUR-Neurobiosciences—Basque Government.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Industrial By-Products As a Novel Circular Source of Biocompatible Extracellular Vesicles

  • Lorca, Cristina
  • Laparra, Moisés
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Casaní, Laura|||0000-0002-0139-4588
  • Florit, Sergi
  • Jové, Mariona|||0000-0001-5577-6162
  • Mota-Martorell, Natàlia|||0000-0001-5937-7070
  • Vilella, Elisabet|||0000-0002-1887-5919
  • Gallart-Palau, Xavier
  • Serra, Aida
Extracellular vesicles (EVs) constitute an intricate system of molecular exchange that has recently gained tremendous interest. However, sustainable sources of safe biological EVs remain scarce and elusive. This study explores and defines the use of food industry by-products (BP) as a circular source of safe biocompatible EVs. Averaged diameter and molecular compositions indicate a large yield of exosomes and high abundancy of membrane lipids with signaling capacity in these vesicles. Complex proteomes mimicking those circulating in human blood plasma are also identified. Furthermore, BP-EVs do not show relevant cytotoxicity and display excellent oral and intravenous bioavailability together with specific organ targeting capacity. Collectively, it is believed that the novel findings reported here will open substantial venues for the use of BP as an optimal source of biocompatible nanovesicles in manifold applications of the biotechnological and biomedical fields.